Reference is made to Kanger’s announcement on 29 September 2020 (ref no. GA1-29092020-00043) whereby the Group had entered into a three-year collaboration agreement with Sinopharm Group Hunan Changde Medical Co Ltd for the distribution of Covid-19 vaccines and medical equipment in Malaysia which are developed by China National Pharmaceutical Group Corporation (“Sinopharm”).
The Board of Directors of Kanger is pleased to announce that National Institutes of Biotechnology Malaysia (“NIBM”), an agency under the Ministry of Science, Technology and Innovation Malaysia has issued a letter which states that NIBM has no objections for Kanger to communicate with the relevant stakeholders at Sinopharm to purchase Covid-19 vaccines for private sector use in Malaysia.
trap high is not an issue if you planned well your investment distribution in multiple stocks. Buy second time at much lower price. its much more helpful i think. Dont panic selling. Paper loss and realized loss, which one is more terrible.
this emil, go every where... nothing but spread negative thinking... this will drop that will drop... every counter at bursa will drop... lanpar also can drop
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
vaccineisreal
290 posts
Posted by vaccineisreal > 2020-11-23 14:31 | Report Abuse
htt, bulldog, freddie all trapped in this counter. They want you to buy their tickets!